Cargando…

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury

Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) presents with a range of both phenotypes and severity, from acute hepatitis indistinguishable of viral hepatitis to autoimmune syndromes, steatosis or rare chronic vascular syndromes, and fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega-Alonso, Aida, Stephens, Camilla, Lucena, M. Isabel, Andrade, Raúl J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881536/ https://www.ncbi.nlm.nih.gov/pubmed/27187363 http://dx.doi.org/10.3390/ijms17050714

Ejemplares similares

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury
por: Caballano-Infantes, Estefanía, et al.
Publicado: (2021)

Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
por: Moya-García, Aurelio A., et al.
Publicado: (2022)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate–Induced Liver Injury in Spanish Patients
por: Stephens, Camilla, et al.
Publicado: (2016)

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review
por: Sanabria-Cabrera, Judith, et al.
Publicado: (2022)

Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
por: Niu, Hao, et al.
Publicado: (2022)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
por: Mikus, Maria, et al.
Publicado: (2016)

Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
por: Ulzurrun, Eugenia, et al.
Publicado: (2014)

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review
por: Licata, Anna, et al.
Publicado: (2022)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
por: Ulzurrun, Eugenia, et al.
Publicado: (2015)

Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016)

Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
por: Rangel, Maria Adriana, et al.
Publicado: (2017)

Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
por: Bessone, Fernando, et al.
Publicado: (2022)

Recreational Drugs and the Risk of Hepatocellular Carcinoma
por: Pinazo-Bandera, José M., et al.
Publicado: (2022)

Next-Generation Sequencing of PTGS Genes Reveals an Increased Frequency of Non-synonymous Variants Among Patients With NSAID-Induced Liver Injury
por: Lucena, María Isabel, et al.
Publicado: (2019)

Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports
por: Björnsson, Einar S., et al.
Publicado: (2022)

Clinical Features of Drug-induced Liver Injury According to Etiology
por: Lee, Byoung Moo, et al.
Publicado: (2015)

Histopathological Features of Drug-Induced Liver Injury Secondary to Osimertinib
por: González, Iván, et al.
Publicado: (2019)

Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans
por: Ravindra, Kodihalli C., et al.
Publicado: (2023)

Trends in Qualifying Biomarkers in Drug Safety. Consensus of the 2011 Meeting of the Spanish Society of Clinical Pharmacology
por: Agúndez, José A. G., et al.
Publicado: (2012)

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
por: Gerussi, Alessio, et al.
Publicado: (2021)

Clinical characteristics of drug-induced liver injury and related risk factors
por: Lu, Ren-Jie, et al.
Publicado: (2016)

Characterizing Highly Cited Papers in Mass Cytometry through H-Classics
por: Di Zeo-Sánchez, Daniel E., et al.
Publicado: (2021)

Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients
por: Gaude, Gajanan S., et al.
Publicado: (2015)

Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Zhang, Zhibin, et al.
Publicado: (2020)

AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons
por: Pinazo-Bandera, Jose María, et al.
Publicado: (2023)

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
por: Wang, Shuting, et al.
Publicado: (2018)

Factors affecting drug-induced liver injury: antithyroid drugs as instances
por: Heidari, Reza, et al.
Publicado: (2014)

Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China
por: Zhu, Yun, et al.
Publicado: (2015)

Correlation between serum cytokines and clinicopathological features in patients with drug-induced liver injury
por: Zhang, Yu, et al.
Publicado: (2022)

Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017)

Drug-induced liver injury
por: Suh, Jeong Ill
Publicado: (2019)

Drug-induced liver injury
por: Kumachev, Alexander, et al.
Publicado: (2021)

The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis
por: Ju, Hye Young, et al.
Publicado: (2012)

Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study
por: Yang, Hong-Yi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nsjv0r1334ft8umuifs053amcq